Nano-oligosaccharide factor (sucrose octasulfate dressing based on technology lipido-colloid, TLC-NOSF) in the management of diabetes related diabetic foot ulcers.

Authors

  • Chen Wenge Chief Physician and Head of Vascular Surgery. First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City
  • Yang Xingbo Chief Physician and Head of the Wound Repair Department. The Fifth Hospital of Harbin City, Harbin City
  • Zhao Jin Chief Physician and Head of the Wound Repair Department. Central Hospital of Jinzhou, Jinzhou City
  • Zhao Hanwei Doctor in charge of Proctology Department. Harbin Traditional Chinese Medicine Hospital, Harbin City
  • Liu Qi Resident at Vascular Surgery Department, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City
  • Emilio Galea Urgo Medical

DOI:

https://doi.org/10.55067/jifaf.v1i4.6

Keywords:

diabetic foot ulcers, TLC-NOSF, wound healing

Abstract

The ever-increasing numbers of people suffering from diabetes mellitus is alarming. This intensification has also seen an upsurge in diabetes related lower extremity complications. This poses a rise in the burden on health care professionals who treat these wounds, an increase in financial burdens to health care systems, as well as a decrease in the health-related quality of life of the sufferers. An evidence-based standard of care in the management of these patients, such as recommendations by the International Working Group on the Diabetic Foot (IWGDF), is of utmost importance. Local wound therapy in the form of dressings, has been found to be beneficial in improving wound healing rates. Nano-oligosaccharide factor (sucrose octasulfate dressing based on technology lipido-colloid, TLC-NOSF) is one such treatment that is backed by evidence including double-blind randomised control trials and recommendations by international bodies such as the IWGDF. This paper portrays three cases from Harbin City, China, where the TLC-NOSF dressing was evaluated in patients suffering from diabetic foot ulcers. 

References

Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020 Sep 8;10(1):14790. doi: 10.1038/s41598-020-71908-9. PMID: 32901098; PMCID: PMC7478957.

International Diabetes Federation (IDF). Diabetes facts & figures. Last update: 09/12/2021. Accessed 20th January 2022; Available from: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html#:~:text=The%20IDF%20Diabetes%20Atlas%20Tenth,and%20783%20million%20by%202045.

Wu L. Rate of diabetes in China explosive. World Health Organization news release. 2016. Accessed 20th January 2022; Available from: https://www.who.int/china/news/detail/06-04-2016-rate-of-diabetes-in-china-explosive-

Atosona A, Larbie C. Prevalence and Determinants of Diabetic Foot Ulcers and Lower Extremity Amputations in Three Selected Tertiary Hospitals in Ghana. J Diabetes Res. 2019 Feb 11;2019:7132861. doi: 10.1155/2019/7132861. PMID: 30886869; PMCID: PMC6388336.

Abdissa D, Hamba N, Kene K, Bedane DA, Etana G, Muleta D, Gerbi A. Prevalence and Determinants of Peripheral Neuropathy among Type 2 Adult Diabetes Patients Attending Jimma University Medical Center, Southwest Ethiopia, 2019, an Institutional-Based Cross-Sectional Study. J Diabetes Res. 2020 Jun 29;2020:9562920. doi: 10.1155/2020/9562920. PMID: 32685561; PMCID: PMC7341394.

van Netten JJ, Price PE, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, Bus SA; International Working Group on the Diabetic Foot. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:84-98. doi: 10.1002/dmrr.2701. PMID: 26340966.

Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017 Jun 15;376(24):2367-2375. doi: 10.1056/NEJMra1615439. PMID: 28614678.

Jiang X, Deng F, Rui S, Ma Y, Wang M, Deng B, Wang H, Du C, Chen B, Yang X, Boey J, Armstrong DG, Deng W, Duan X. The Evaluation of Gait and Balance for Patients with Early Diabetic Peripheral Neuropathy: A Cross-Sectional Study. Risk Manag Healthc Policy. 2022 Mar 30;15:543-552. doi: 10.2147/RMHP.S361698. PMID: 35386278; PMCID: PMC8977473.

Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016 Nov;33(11):1493-1498. doi: 10.1111/dme.13054. Epub 2016 Jan 10. PMID: 26666583.

Lavery LA, Hunt NA, Ndip A, Lavery DC, Van Houtum W, Boulton AJ. Impact of chronic kidney disease on survival after amputation in individuals with diabetes. Diabetes Care. 2010 Nov;33(11):2365-9. doi: 10.2337/dc10-1213. Epub 2010 Aug 25. PMID: 20739688; PMCID: PMC2963496.

Hinchliffe RJ, Brownrigg JR, Andros G, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers J, Shearman CP, Zierler RE, Schaper NC; International Working Group on the Diabetic Foot. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:136-44. doi: 10.1002/dmrr.2705. PMID: 26342204.

Bus SA, van Deursen RW, Armstrong DG, Lewis JE, Caravaggi CF, Cavanagh PR; International Working Group on the Diabetic Foot. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:99-118. doi: 10.1002/dmrr.2702. PMID: 26342178.

Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA; IWGDF Editorial Board. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266. doi: 10.1002/dmrr.3266. PMID: 32176447.

Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186-196. doi: 10.1016/S2213-8587(17)30438-2. Epub 2017 Dec 20. Erratum in: Lancet Diabetes Endocrinol. 2018 Mar 6; PMID: 29275068.

White R, Cowan T, Glover D. Supporting evidence based practice: a clinical review of TLC healing matrix. 2015. http://bit.ly/2sHLVyU Accessed 21st January 2022

Lázaro-Martínez JL, García-Madrid M, García-Alamino JM, Bohbot S, García-Klepzig JL, García-Álvarez Y. Increasing Transcutaneous Oxygen Pressure in Patients With Neuroischemic Diabetic Foot Ulcers Treated With a Sucrose Octasulfate Dressing: A Pilot Study. Int J Low Extrem Wounds. 2020 Aug 28:1534734620952244. doi: 10.1177/1534734620952244. Epub ahead of print. PMID: 32856522.

Nair H, Venkateshwaran N, Seetharaman S S, Deng W, Uthaipaisanwong A, Galea E. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review. J Wound Care. 2021 Apr 1;30(Sup4):S42-S52. doi: 10.12968/jowc.2021.30.Sup4.S42. PMID: 33856929.

Zhong L, Wang J, Zhu S, Jian D, Fan X, Galea E. Diabetic foot ulcer management with TLC-NOSF (Technology Lipido-colloid Nano-oligosaccharide Factor) wound dressings. Wounds International. 2021; 12(4): 54-61. Available from: https://www.woundsinternational.com/resources/details/diabetic-foot-ulcer-management-tlc-nosf-technology-lipido-colloid-nano-oligosaccharide-factor-wound-dressings

Atkin L, Tickle J, McDonald A, Nichols J, Waller C, Welch D, Murray S, Goodeve M, Mullings J, Murphy N, Hart S. UrgoStart Plus® in real life. Wounds UK. Supplement. Available from:https://www.wounds-uk.com/resources/details/urgostart-plus-real-life. Accessed 24th January 2022

Lo ZJ, Surendra NK, Saxena A, Car J. Clinical and economic burden of diabetic foot ulcers: A 5-year longitudinal multi-ethnic cohort study from the tropics. Int Wound J. 2021 Jun;18(3):375-386. doi: 10.1111/iwj.13540. Epub 2021 Jan 26. PMID: 33497545; PMCID: PMC8244009.

Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016. Diabetes Care. 2020 May;43(5):964-974. doi: 10.2337/dc19-1614. Epub 2020 Mar 5. PMID: 32139380.

National Institute for Health and Care Excellence. UrgoStart for Treating Diabetic Foot Ulcers and Leg Ulcers. Medical Technologies Guidance 2019 [MTG42]. Available at: https://www.nice.org.uk/guidance/mtg42. Accessed 24th January 2022.

Downloads

Published

2022-04-25

How to Cite

1.
Wenge C, Xingbo Y, Jin Z, Hanwei Z, Qi L, Galea E. Nano-oligosaccharide factor (sucrose octasulfate dressing based on technology lipido-colloid, TLC-NOSF) in the management of diabetes related diabetic foot ulcers. . J Int Foot Ankle [Internet]. 2022 Apr. 25 [cited 2022 May 18];1(4). Available from: https://internationalfootankle.org/journal/index.php/JIFAF/article/view/6

Issue

Section

Articles